Immunological Control of Herpes Simplex Virus Type 1 Infection: A Non-Thermal Plasma-Based Approach
Viruses · 23.04.2025 · 17 (5) · 600
DOI: 10.3390/v17050600 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Viruses, online erschienen am 23.04.2025. Verfasst von Julia Sutter und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Molecular Virology and Gene Therapy, Institute for Molecular Medicine and Infectious Disease, and Department of Microbiology and Immunolog…. Hauptthemen laut MEDLINE: Herpesvirus 1, Human, Herpes Simplex, Plasma Gases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 262 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Drexel Coulter Translational Research Partnership Program.
Abstract (Originalsprache)
Herpes simplex virus type 1 (HSV-1) causes a lifelong infection due to latency established in the trigeminal ganglia, which is the source of recurrent outbreaks of cold sores. The lifelong persistence of HSV-1 is further facilitated by the lack of cure strategies, unsuccessful vaccine development, and the inability of the host immune system to clear HSV-1. Despite the inefficiencies of the immune system, the course of HSV-1 infection remains under strict immunological control. Specifically, HSV-1 is controlled by a CD8+ T cell response that is cytotoxic to HSV-1-infected cells, restricts acute infection, and uses noncytolytic mechanisms to suppress reactivation in the TG. When this CD8+ T cell response is disrupted, reactivation of latent HSV-1 occurs. With antiviral therapies unable to cure HSV-1 and prophylactic vaccine strategies failing to stimulate a protective response, we propose non-thermal plasma (NTP) as a potential therapy effective against recurrent HSV-1 infection. We have demonstrated that NTP, when applied directly to HSV-1-infected cells, has antiviral effects and stimulates cellular stress and immunomodulatory responses. We further propose that the direct effects of NTP will lead to long-lasting indirect effects such as reduced viral seeding into the TG and enhanced HSV-1-specific CD8+ T cell responses that exert greater immune control over HSV-1 infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Molecular Virology and Gene Therapy, Institute for Molecular Medicine and Infectious Disease, and Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, PA 19102, USA.
- Immune Cell Regulation and Targeting Program, Sidney Kimmel Comprehensive Cancer Center Consortium at Jefferson Health, Philadelphia, PA 19107, USA.
ORCID-Profile: Julia Sutter, Jennifer L Hope, Brian Wigdahl, Vandana Miller, Fred C Krebs
Förderung
- Drexel Coulter Translational Research Partnership Program
Zitieren
APA
Sutter, J., Hope, J. L., Wigdahl, B., Miller, V., & Krebs, F. C. (2025). Immunological Control of Herpes Simplex Virus Type 1 Infection: A Non-Thermal Plasma-Based Approach. Viruses, 17(5), 600. https://doi.org/10.3390/v17050600
Vancouver
Sutter J, Hope JL, Wigdahl B, Miller V, Krebs FC. Immunological Control of Herpes Simplex Virus Type 1 Infection: A Non-Thermal Plasma-Based Approach. Viruses. 2025;17(5):600. doi:10.3390/v17050600
BibTeX
@article{Sutter2025,
author = {Sutter, Julia and Hope, Jennifer L and Wigdahl, Brian and Miller, Vandana and Krebs, Fred C},
title = {Immunological Control of Herpes Simplex Virus Type 1 Infection: A Non-Thermal Plasma-Based Approach},
journal = {Viruses},
year = {2025},
volume = {17},
number = {5},
pages = {600},
doi = {10.3390/v17050600}
}
EUVIMED